TRIM22 and osteosarcoma: Furthermore, studies have found that TRIM22 regulates the proliferation and metastasis of osteosarcoma (OS) cells by promoting NRF2 degradation and activating the ROS/AMPK/mTOR/autophagy signaling pathway (Liu W et al., 2022).